ST Hai Li: The secondary subsidiary has completed the industrial and commercial registration and plans to acquire the equity of seven dental chain companies.

ST HaiLi announced that its holding subsidiary, Ruisheng Biology, jointly established Jiangsu HaiLi Oral Medical Management Co., Ltd. with Zou Chunyang and Xie Shouliang, completed the industrial and commercial registration procedures and obtained the business license on May 20, 2026. The registered capital is 15 million yuan, with the equity structure being 51% for Ruisheng Biology, 44% for Zou Chunyang, and 5% for Xie Shouliang. As of the disclosure date of the announcement, the industrial and commercial change registration procedures for the equity transfer of seven dental chain companies in Yangzhou and Changzhou have been completed. HaiLi Oral plans to acquire a total of 100% equity of the above-mentioned companies. There is uncertainty in the related transfer and integration work.